Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial (Q46791835)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2008

Language	Label	Description	Also known as
English	Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial	scientific article published in April 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

Long-term weight loss observed with olanzapine orally disintegrating tablets in overweight patients with chronic schizophrenia. A 1 year open-label, prospective trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

0 references

1 reference

based on heuristic

inferred from title

author name string

Bharat Chawla

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

Heather Luxton-Andrew

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

Human Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

23

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

211-216

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

High-dose olanzapine orally disintegrating tablets for treatment-resistant psychosis

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

21 January 2018

Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain volume changes in the first year of illness and 5-year outcome of schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Amantadine for weight gain associated with olanzapine treatment

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Weight loss after switching from conventional olanzapine tablets to orally disintegrating olanzapine tablets

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipsychotic-induced weight gain

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Ghrelin: structure and function

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose olanzapine-induced improvement of preexisting type 2 diabetes mellitus in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipsychotic drug effects on brain morphology in first-episode psychosis

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjects

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine increases plasma ghrelin level in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of serum ghrelin levels with body mass index and carbohydrate metabolism in patients treated with atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Size of burden of schizophrenia and psychotic disorders

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment with atypical antipsychotics and risk of weight gain

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

A program for managing weight gain associated with atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.921

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUP.921

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219624

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46791835&oldid=2132247618"